Delhi High Court gave a green signal to pharmaceutical companies Biocon and Mylan to manufacture and sell its biosimilar drug Trastuzumab for early breast cancer and metastatic gastric cancer.
Tags : DELHI HIGH COURT BIOSIMILAR CANCER DRUG
Share :